Background/Purpose:

Routine Assessment of Patient Index Data 3 (RAPID 3) is a patient based questionnaire which was designed for evaluation of disease activity without formal joint counts for rheumatoid arthritis (RA) for busy clinical settings. Besides RA, it’s usage is being serached for some other diseases, too. We aimed to search the effectiveness of RAPID 3 in evaluating severity of fibromyalgia (FM) which is a generalized pain syndrome sharing many symptoms of RA like stiffness and fatigue besides many somatic symptom.

Methods: 38 female volunteered patients with FM were involved in the study. All patients were requested to complete the RAPID 3, Fibromyalgia Impact Questionnaire (FIQ), Revised Fibromyalgia Impact Questionnaire (FIQR) and FM symptom severity scale. 

Results: Mean age of the patients were 46±10,9 years and the mean disease duration was 4,8±3.8 years.  There were significant correlations between RAPID 3 and FIQR (r=0.598 p=0.000), symptom severity (r=0.573 p=0.000), FIQ total (r=0.742 p=0.000) and subgroups of FIQ (FIQ physical impairment r=0.434 p=0.007, feel good r=0.524 p=0.001, work missed r=0.577 p=0.000, do work r=0.634 p=0.000, pain r=0.733 p=0.000, fatigue r=0.045 p=0.005, stiffness r=0.492 p=0.002, anxiety r=0.378 p=0.019, depression r=0.398 p=0.013 except rested r=0.197 p=0.236. The correlation of FIQR and FIQ total was also good (r=0.763 p=0.000). The correlations of FIQ total and FIQR with symptom severity were r=0.626 p=0.000 and r=0.481 p=0.005 respectively.   

Conclusion: RAPID 3 has a good correlation with FIQ, FIQR and symptom severity scale which are gold standarts in follow up of FM. Though it is not a spesific questionnaire for FM, it successfully puts forward the severity of the disease in a quicker and easier way. These preliminary results justify further investigation of the usage of this questionnaire in FM.

---

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/routine-assessment-of-patient-index-data-3-in-fibromyalgia-a-rapid-and-reliable-instrument-for-evaluating-disease-severity/